SCHEMBL456709

SCHEMBL456709

C[C@@H](CN)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2191 1.00
SCHEMBL21114361 1.00 GABRR1 (0.65)
SCHEMBL565484 1.00
Hydrochloric Acid SCHEMBL463250 0.97
Water SCHEMBL1565541 0.97
Hydrochloric Acid SCHEMBL27603637 0.97
Hydrochloric Acid SCHEMBL27599300 0.97
Hydrochloric Acid SCHEMBL2582220 0.97
Ethylenediamine SCHEMBL8828910 0.94 GABRR1 (0.67)
Methylmalonic Acid SCHEMBL17223948 0.91 GABRR1 (0.56)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 301 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250161396-A1 COMPOSITION AND METHOD FOR IMPROVING LIPID METABOLISM FUNCTION OF SUBJECT NANJING NUTRABUILDING BIO-TECH CO., LTD. (CN) 2025-05-22 US claimed
US-20250009695-A1 COMPOSITIONS AND METHODS FOR PROMOTING GLYCOGEN SYNTHASE ACTIVITY AND AUGMENTING GLYCOGEN STORAGE CAPABILITY NANJING NUTRABUILDING BIO-TECH CO., LTD. (CN) 2025-01-09 US claimed
CN-119246661-A Metabolic syndrome and its preclinical diagnostic marker and application 上海交通大学医学院附属仁济医院 2025-01-03 CN claimed
US-12171736-B2 Compositions and methods for promoting glycogen synthase activity and augmenting glycogen storage capability NANJING NUTRABUILDING BIO-TECH CO., LTD. (CN) 2024-12-24 US claimed
US-20240398735-A1 COMPOSITION AND METHODS OF TREATMENT USING SYNERGISTICALLY - ENHANCED SUPPLEMENTATION Xygenyx Inc. 2024-12-05 US claimed
US-20240115530-A1 ADMINISTRATION OF BAIBA TO INCREASE BENEFIT OF LOSING WEIGHT OF INTERMITTENT FASTING NANJING NUTRABUILDING BIO-TECH CO., LTD. (CN) 2024-04-11 US claimed
EP-4337187-A1 ADMINISTRATION OF BAIBA TO INCREASE BENEFIT OF LOSING WEIGHT OF INTERMITTENT FASTING Nanjing Nutrabuilding Bio-Tech Co., Ltd. (CN) 2024-03-20 EP claimed
CN-117561056-A Administration of beta-aminoisobutyric acid increases the benefits of intermittent fasted weight loss 南京纽邦生物科技有限公司 2024-02-13 CN claimed
US-20240041809-A1 COMPOSITIONS AND METHODS FOR PROMOTING GLYCOGEN SYNTHASE ACTIVITY AND AUGMENTING GLYCOGEN STORAGE CAPABILITY NANJING NUTRABUILDING BIO-TECH CO., LTD. (CN) 2024-02-08 US claimed
EP-4297742-A1 COMPOSITIONS AND METHODS FOR PROMOTINGGLYCOGEN SYNTHASE ACTIVITY AND AUGMENTING GLYCOGEN STORAGE CAPABILITY Nanjing Nutrabuilding Bio-Tech Co., Ltd. (CN) 2024-01-03 EP claimed
WO-2022268049-A1 ADMINISTRATION OF BAIBA TO INCREASE BENEFIT OF LOSING WEIGHT OF INTERMITTENT FASTING NANJING NUTRABUILDING BIO-TECH CO., LTD (CN) 2022-12-29 WO claimed
US-20220347141-A1 METHODS OF TREATING PHOSPHATE CONCENTRATION DISORDERS WITH L-BAIBA THE TRUSTEES OF INDIANA UNIVERSITY 2022-11-03 US claimed
WO-2022218320-A1 COMPOSITIONS AND METHODS FOR PROMOTINGGLYCOGEN SYNTHASE ACTIVITY AND AUGMENTING GLYCOGEN STORAGE CAPABILITY NANJING NUTRABUILDING BIO-TECH CO., LTD. (CN) 2022-10-20 WO claimed
US-20220054441-A1 COMPOSITIONS OF BETA-AMINOISOBUTYRIC ACID AND METHODS FOR USE THEREOF NANJING NUTRABUILDING BIO-TECH CO., LTD. (CN) 2022-02-24 US claimed
WO-2017189528-A1 CORROSION INHIBITOR COMPOSITIONS AND METHODS OF USING SAME Ecolab USA, Inc. (US) 2017-11-02 WO claimed
US-20170306504-A1 CORROSION INHIBITOR COMPOSITIONS AND METHODS OF USING SAME CHAMPIONX LLC 2017-10-26 US claimed
US-20110070218-A1 METHODS OF TREATING CANCER OF THE CENTRAL NERVOUS SYSTEM YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2011-03-24 US claimed
US-20090280102-A1 COMPOSITIONS FOR ENHANCING THE ANTIBACTERIAL ACTIVITY OF MYELOPEROXIDASE AND METHODS OF USE THEREOF EXOXEMIS, INC. (US) 2009-11-12 US claimed
EP-1448177-A1 AMINO DIOLS USEFUL IN THE TREATMENT OF ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2004-08-25 EP claimed
WO-2003043618-A2 AMINO DIOLS USEFUL IN THE TREATMENT OF ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2003-05-30 WO claimed